Wellness Oncology and Hematology

West Hills, California 91307

1 studies enrolling now · 3 studies all time

What they study most

Multiple Myeloma

Studies at this site

• A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients — Recruiting now
• Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients — Stopped early
• Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib — Stopped early